AOD-9604

AOD-9604 is a synthetic peptide corresponding to a modified C-terminal fragment of human growth hormone (residues 176–191), with an added N-terminal tyrosine and a cyclic disulfide bond between positions 7 and 14. It is a frequent subject of laboratory research and is supplied as a lyophilized powder for research use only.

In published in vitro and preclinical research, AOD-9604 has been studied in connection with beta-adrenergic receptor and cyclic AMP (cAMP) signaling pathways, and has been characterized as not activating the growth hormone receptor or the IGF-1 axis — a mechanistic distinction studied in cell-culture and animal research models. These findings derive from laboratory research and do not describe or imply any effect, benefit, or use in humans or animals.

Published literature has examined AOD-9604 across a range of cell-culture and animal research models relating to receptor signaling biology. These reports reflect controlled laboratory conditions only and do not translate to any research amount, clinical use, or application outside these controlled conditions. Its mechanism is studied alongside related research compounds such as SLU-PP-332, 5-Amino-1MQ, and MOTS-C.

For further reading, see published research on AOD-9604 on PubMed.

Product Specifications

For Research Use Only. Not for use in diagnostic, medical, or human or animal in-vivo procedures. This product is sold exclusively for in-vitro laboratory research use. It is not a drug, dietary supplement, food, or cosmetic and has not been approved by the U.S. Food and Drug Administration for any use. Not intended to diagnose, manage, mitigate, or prevent any illness or medical condition. Not for human or animal consumption.